Ovid Therapeutics Derivative Contract Liabilities (Quarterly) Insights

Ovid Therapeutics, Inc. (OVID)

1.615 -0.04 (-2.12%) USD | NASDAQ | Feb 27, 10:32

View Derivative Contract Liabilities (Quarterly) for OVID.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Derivative Contract Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Derivative Contract Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Derivative Contract Liabilities (Quarterly) Benchmarks

Start Trial

Cassava Sciences, Inc.	--
PTC Therapeutics, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	--